NEW YORK (GenomeWeb News) – Link Technologies has licensed Agilent Technologies' RNA monomers technology, the Scottish company said today.

Link Technologies said it will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.

The company makes reagents for oligonucleotide synthesis and modification, and it offers a variety of products including phosphoramidites, solid supports, modifiers, labels, bioconjugation and oligo-immobilisation products.

Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.